Literature DB >> 8578548

Role of tissue factor in disseminated intravascular coagulation.

H Asakura1, Y Kamikubo, A Goto, Y Shiratori, M Yamazaki, H Jokaji, M Saito, C Uotani, I Kumabashiri, E Morishita.   

Abstract

We examined plasma antigen levels of tissue factor (TF) in 95 cases of disseminated intravascular coagulation (DIC), to investigate the role of TF in DIC. A significant elevation of plasma antigen levels of TF was observed in cases of DIC associated with cancer. However, no such significant elevation was observed in cases of DIC associated with acute promyelocytic leukemia (APL), acute leukemia except APL, blastic crisis of chronic myelogenous leukemia, non-Hodgkin lymphoma (NHL), sepsis or fulminant hepatitis. No significant elevation of TF was observed in patients without DIC, except 4 cases of cancer who developed DIC thereafter. Plasma antigen levels of TF were higher in both cases of DIC with renal failure and chronic renal failure without DIC than its levels in those without renal failure. Therefore, plasma antigen levels of TF in DIC patients with renal failure were considered to be carefully estimated. The levels of TF were decreased with the clinical improvement in some cases of DIC but were further increased or remained at high levels in patients who showed no improvement of DIC. Thus, plasma antigen levels of TF is an important marker to predict the development and/or prognosis of DIC, especially in patients with cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578548     DOI: 10.1016/0049-3848(95)00170-v

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Simple hemorrhage induces tissue factor mRNA in the liver.

Authors:  M Yamashita; J Tanaka; M Yamashita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Blood       Date:  2010-05-06       Impact factor: 22.113

3.  Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.

Authors:  Hiroyasu Suga; Takao Nakagawa; Yukihiro Soga; Yoshizumi Deguchi; Tadashi Suzuki; Norio Miyoshi; Yoshiaki Imamura; Masaru Fukuda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.

Authors:  T Ogiichi; Y Hirashima; S Nakamura; S Endo; M Kurimoto; A Takaku
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  Tissue Factor Facilitates Wound Healing in Human Airway Epithelial Cells.

Authors:  Michael D Davis; Isao Suzaki; Shuichi Kawano; Kosaku Komiya; Qing Cai; Youngman Oh; Bruce K Rubin
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

Review 6.  Tissue factor: a key molecule in hemostatic and nonhemostatic systems.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

7.  Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.

Authors:  Vijender Reddy Vaidyula; Gerard J Criner; Carla Grabianowski; A Koneti Rao
Journal:  Thromb Res       Date:  2009-01-21       Impact factor: 3.944

Review 8.  Role of PDI in regulating tissue factor: FVIIa activity.

Authors:  Narcis I Popescu; Cristina Lupu; Florea Lupu
Journal:  Thromb Res       Date:  2010-02-16       Impact factor: 3.944

9.  Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.

Authors:  Anamika Singh; Guenther Boden; Carol Homko; Jay Gunawardana; A Koneti Rao
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

Review 10.  Recent advances in the research and management of sepsis-associated DIC.

Authors:  Toshiaki Iba; Jean Marie Connors; Isao Nagaoka; Jerrold H Levy
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.